Publications

  1. Borghol AH, Bou Antoun MT, Hanna C, Salih M, Rahbari-Oskoui FF, Chebib FT. Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances. Ren Fail. 2025 Dec; 47 (1):2492374 Epub 2025 Apr 23
    View PubMed
  2. Munairdjy Debeh FG, Ghanem A, Rangarajan V, Borghol AH, Paul S, AlKhatib B, Nader N, Bou Antoun MT, Hanna D, Souvalian L, Li Z, Gregory A, Kline T, Mao MM, Manohar S, Porter IE, Dillon JJ, Kattah A, Khalillullah S, Baker LW, Trautman CL, Hickson LJ, Chebib FT, Aslam N. Multicenter Insights into Peritoneal Dialysis for ADPKD: Role of Cumulative Cystic Organ Volumes in Treatment Complications. Kidney360. 2025 Jul 7 Epub 2025 July 07
    View PubMed
  3. Borghol AH, Munairdjy Debeh FG, Ghanem A, Bou Antoun MT, Rangarajan V, Mina J, Hassanein M, Baker LW, Gupta S, Mao SA, Hunt CL, Hogan MC, Mao MA, Chebib FT. Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic Approach. Kidney360. 2025 Jul 7 Epub 2025 July 07
    View PubMed
  4. Jawaid T, Elbarougy DE, Lavu S, Buia G, Senum SR, Olinger E, Yang H, McDonnell SK, Bublitz JT, Ma J, Audrezet MP, Madsen CD, Schauer RS, Baker TA, Gregory AV, Orr SE, Barroso-Gil M, Neatu R, Joli G, Dahl NK, Kline TL, Gillion V, Dahan K, Jouret F, Perrone RD, Steinman TI, Peters DJM, Gitomer BY, Watnick TJ, Coto E, Chebib FT, Hogan MC, Olson JE, Larson NB, Ars E, Halbritter J, Demoulin N, Torres VE, Sayer JA, Cornec-Le Gall E, Harris PC, Genomics England Research Consortium, UK Biobank, HALT PKD, DIPAK, TAME PKD, Genkyst studies, Mayo Clinic Biobank, and Regeneron Genetics Center. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. J Am Soc Nephrol. 2025 Jun 1; 36 (6):1056-1071 Epub 2025 Feb 03
    View PubMed
  5. Borghol AH, Alkhatib B, Zayat R, Ravikumar NPG, Munairdjy Debeh FG, Ghanem A, Mina J, Mao MA, Dahl NK, Hickson LJ, Aslam N, Torres VE, Brown RD Jr, Tawk RG, Chebib FT. Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management. Mayo Clin Proc. 2025 Jun; 100 (6):1030-1050 Epub 2025 May 03
    View PubMed
  6. Wigerinck S, Schellekens P, Smith BH, Hanna C, Dachy A, Chedid M, Borghol AH, Senum SR, Bockenhauer D, Harris PC, Jouret F, Bammens B, Chebib FT, Mekahli D. Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40. Pediatr Nephrol. 2025 Jun; 40 (6):1997-2007 Epub 2025 Feb 01
    View PubMed
  7. Chebib FT, Hanna C, Harris PC, Torres VE, Dahl NK. Autosomal Dominant Polycystic Kidney Disease: A Review. JAMA. 2025 May 20; 333 (19):1708-1719
    View PubMed
  8. Geertsema P, Gansevoort RT, Arici M, Capasso G, Cornec-Le-Gall E, Furlano M, Fuster DG, Galletti F, Gomez-Dos-Santos V, Perez-Gomez MV, Goumenos D, Halbritter J, Jambon E, Korst U, Leliveld AM, Felip MM, Figueiredo A, Nijenhuis T, Olsburgh J, Pol RA, Sayer JA, Stippel D, Torra R, Muller RU, Casteleijn NF. Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group. Nephrol Dial Transplant. 2025 Jan 23 [Epub ahead of print]
    View PubMed
  9. Hoover E, Cambareri H, Chapman AB, Chebib FT, Moore S, Perrone RD, Garimella PS. Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program. Kidney360. 2025 Jan 1; 6 (1):159-166 Epub 2024 Nov 19
    View PubMed
  10. Chebib FT, Dahl N, Zhou X, Garbinsky D, Wang J, Nunna S, Oberdhan D, Fernandes AW. Tolvaptan and Autosomal Dominant Polycystic Kidney Disease Progression in Individuals Aged 18-35 Years: A Pooled Database Analysis. Kidney Med. 2025 Jan; 7 (1):100935 Epub 2024 Nov 14
    View PubMed
  11. Fan Q, Hadla M, Peterson Z, Nelson G, Ye H, Wang X, Mardirossian JM, Harris PC, Alper SL, Prakash YS, Beyder A, Torres VE, Chebib FT. Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo. Kidney360. 2024 Nov 1; 5 (11):1601-1612 Epub 2024 Oct 02
    View PubMed
  12. Ghanem A, Borghol AH, Munairdjy Debeh FG, Paul S, AlKhatib B, Harris PC, Garimella PS, Hanna C, Kline TL, Dahl NK, Chebib FT. Biomarkers of Kidney Disease Progression in ADPKD. Kidney Int Rep. 2024 Oct; 9(10):2860-2882. Epub 2024 Jul 14.
    View PubMed
  13. Alper SL, Chebib FT. Dietary potassium loads call on intercalated cell PIEZO1 to go with the flow. Kidney Int. 2024 Sep; 106 (3):350-353 Epub 2024 May 24
    View PubMed
  14. Ebrahimi N, Garimella PS, Chebib FT, Sparks MA, Lerma EV, Golsorkhi M, Ghozloujeh ZG, Abdipour A, Norouzi S. Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review. Kidney360. 2024 Aug 1; 5 (8):1200-1206 Epub 2024 July 08
    View PubMed
  15. Chebib FT, Dahl NK. CKD Risk Stratification: The Emerging Role of Kidney Volume Imaging. J Am Soc Nephrol. 2024 Jul 25; 35 (9):1146-8 Epub 2024 July 25
    View PubMed
  16. Milutinovic S, Bell A, Jancic P, Stanojevic D, Borghol AH, Mina J, Chebib FT, Khambati I, Escarcega RO, Wood MJ. Spontaneous Coronary Artery Dissection in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of the Literature. J Pers Med. 2024 Jun 29; 14 (7) Epub 2024 June 29
    View PubMed
  17. Chebib FT, Nowak KL, Chonchol MB, Bing K, Ghanem A, Rahbari-Oskoui FF, Dahl NK, Mrug M. Polycystic Kidney Disease Diet: What is Known and What is Safe. Clin J Am Soc Nephrol. 2024 May 1; 19 (5):664-682 Epub 2023 Sept 20
    View PubMed
  18. Chedid M, Chebib FT, Dahlen E, Mueller T, Schnell T, Gay M, Hommos M, Swaminathan S, Garg A, Mao M, Amberg B, Balderes K, Johnson KF, Bishop A, Vaughn JK, Hogan M, Torres V, Chaudhry R, Zoghby Z. An Electronic Health Record-Integrated Application for Standardizing Care and Monitoring Patients With Autosomal Dominant Polycystic Kidney Disease Enrolled in a Tolvaptan Clinic: Design and Implementation Study. JMIR Med Inform. 2024 May 1; 12:e50164 Epub 2024 May 01
    View PubMed
  19. Chebib FT, Tawk RG. All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: CON. Kidney360. 2024 Apr 1; 5 (4):495-498 Epub 2023 Nov 22
    View PubMed
  20. Thompson WS, Babayev SN, McGowan ML, Kattah AG, Wick MJ, Bendel-Stenzel EM, Chebib FT, Harris PC, Dahl NK, Torres VE, Hanna C. State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies. J Am Soc Nephrol. 2024 Feb 1; 35 (2):235-248 Epub 2023 Oct 26
    View PubMed
  21. Naser JA, Luis SA, Pislaru SV, Michelena HI, Kennedy AM, Eleid MF, Crestanello JA, Chebib FT, Pellikka PA, Nkomo VT. Impact on Kidney Function and Medium-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. Am J Cardiol. 2024 Jan 1; 210:163-171 Epub 2023 Oct 19
    View PubMed
  22. Dahl NK, Bloom MS, Chebib FT, Clark D, Westemeyer M, Jandeska S, Zhang Z, Milo-Rasouly H, Kolupaeva V, Marasa M, Broumand V, Fatica RA, Raj DS, Demko ZP, Marshall K, Punj S, Tabriziani H, Bhorade S, Gharavi AG. The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease. J Am Soc Nephrol. 2023 Dec 1; 34 (12):2039-2050 Epub 2023 Oct 05
    View PubMed
  23. Wigerinck S, Gregory AV, Smith BH, Iliuta IA, Hanna C, Chedid M, Kaidbay HN, Senum SR, Shukoor S, Harris PC, Torres VE, Kline TL, Chebib FT. Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study. Clin Kidney J. 2023 Oct; 16 (10):1691-1700 Epub 2023 May 23
    View PubMed
  24. Ritchie L, Zayat R, Chebib FT. Oral-facial-digital syndrome type 1: the kidney cystic disease that mimics autosomal dominant polycystic kidney disease. Kidney Int. 2023 Aug; 104 (2):399
    View PubMed
  25. Gregory AV, Chebib FT, Poudyal B, Holmes HL, Yu ASL, Landsittel DP, Bae KT, Chapman AB, Frederic RO, Mrug M, Bennett WM, Harris PC, Erickson BJ, Torres VE, Kline TL. Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation. Kidney Int. 2023 Aug; 104 (2):334-342 Epub 2023 Feb 01
    View PubMed
  26. Hanna C, Iliuta IA, Besse W, Mekahli D, Chebib FT. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management. Semin Nephrol. 2023 Jul; 43 (4):151434 Epub 2023 Nov 22
    View PubMed
  27. Zubidat D, Hanna C, Randhawa AK, Smith BH, Chedid M, Kaidbay DN, Nardelli L, Mkhaimer YG, Neal RM, Madsen CD, Senum SR, Gregory AV, Kline TL, Zoghby ZM, Broski SM, Issa NS, Harris PC, Torres VE, Sfeir JG, Chebib FT. Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation. Bone Rep. 2023 Jun; 18:101655 Epub 2023 Jan 11
    View PubMed
  28. Chebib FT, Zhou X, Garbinsky D, Davenport E, Nunna S, Oberdhan D, Fernandes A. Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies. Kidney Med. 2023 Jun; 5 (6):100639 Epub 2023 Apr 14
    View PubMed
  29. Chebib FT, Perrone RD. Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges. Adv Kidney Dis Health. 2023 May; 30 (3):261-284
    View PubMed
  30. Potretzke TA, Korfiatis P, Blezek DJ, Edwards ME, Klug JR, Cook CJ, Gregory AV, Harris PC, Chebib FT, Hogan MC, Torres VE, Bolan CW, Sandrasegaran K, Kawashima A, Collins JD, Takahashi N, Hartman RP, Williamson EE, King BF, Callstrom MR, Erickson BJ, Kline TL. Clinical Implementation of an Artificial Intelligence Algorithm for Magnetic Resonance-Derived Measurement of Total Kidney Volume. Mayo Clin Proc. 2023 May; 98 (5):689-700 Epub 2023 Mar 16
    View PubMed
  31. Breysem L, De Keyzer F, Schellekens P, Dachy A, De Rechter S, Janssens P, Vennekens R, Bammens B, Irazabal MV, Van Ongeval C, Harris PC, Mekahli D, CRISP Consortium. Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry. Clin J Am Soc Nephrol. 2023 May 1; 18 (5):581-591 Epub 2023 Feb 17
    View PubMed
  32. Haemmerli J, Morel S, Georges M, Haidar F, Chebib FT, Morita A, Nozaki K, Tominaga T, Bervitskiy AV, Rzaev J, Schaller K, Bijlenga P. Characteristics and Distribution of Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease Compared with the General Population: A Meta-Analysis. Kidney360. 2023 Apr 1; 4 (4):e466-e475 Epub 2023 Feb 20
    View PubMed
  33. Duriseti P, Radhakrishnan Y, Chedid M, Hanna C, Potrezke TA, Chebib FT. Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report. Am J Case Rep. 2023 Feb 27; 24:e938889
    View PubMed
  34. Chedid M, Kaidbay HD, Wigerinck S, Mkhaimer Y, Smith B, Zubidat D, Sekhon I, Prajwal R, Duriseti P, Issa N, Zoghby ZM, Hanna C, Senum SR, Harris PC, Hickson LJ, Torres VE, Nkomo VT, Chebib FT. Cardiovascular Outcomes in Kidney Transplant Recipients With ADPKD. Kidney Int Rep. 2022 Sep; 7(9):1991-2005. Epub 2022 Jun 11.
    View PubMed
  35. Jdiaa SS, Husainat NM, Mansour R, Kalot MA, McGreal K, Chebib FT, Perrone RD, Yu A, Mustafa RA. A Systematic Review of Reported Outcomes in ADPKD Studies. Kidney Int Rep. 2022 Sep; 7 (9):1964-1979 Epub 2022 July 05
    View PubMed
  36. Jouret F, Hogan MC, Chebib FT. A practical guide for the management of acute abdominal pain with fever in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2022 Jul 26; 37 (8):1426-1428
    View PubMed
  37. Radhakrishnan Y, Duriseti P, Chebib FT. Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options. Kidney Res Clin Pract. 2022 Jul; 41 (4):422-431 Epub 2022 Mar 29
    View PubMed
  38. Jones BE, Mkhaimer YG, Rangel LJ, Chedid M, Schulte PJ, Mohamed AK, Neal RM, Zubidat D, Randhawa AK, Hanna C, Gregory AV, Kline TL, Zoghby ZM, Senum SR, Harris PC, Torres VE, Chebib FT. Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2022 Mar 31; 3 (3):465-476 Epub 2021 Dec 07
    View PubMed
  39. Hanna C, Potretzke TA, Chedid M, Rangel LJ, Arroyo J, Zubidat D, Tebben PJ, Cogal AG, Torres VE, Harris PC, Sas DJ, Lieske JC, Milliner DS, Chebib FT. Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series. Kidney Med. 2022 Mar; 4 (3):100419 Epub 2022 Jan 24
    View PubMed
  40. Chedid M, Hanna C, Zaatari G, Mkhaimer Y, Reddy P, Rangel L, Zubidat D, Kaidbay DN, Irazabal MV, Connolly HM, Senum SR, Madsen CD, Hogan MC, Zoghby Z, Harris PC, Torres VE, Johnson JN, Chebib FT. Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease. Am J Nephrol. 2022; 53(4):316-324. Epub 2022 Mar 21.
    View PubMed
  41. Chong GY, Chedid MT, Potretzke TA, Chebib FT. Massive renal angiomyolipomas in tuberous sclerosis complex. Kidney Int. 2021 Dec; 100 (6):1354
    View PubMed
  42. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Answers. Pediatr Nephrol. 2021 Dec; 36 (12):4085-4087 Epub 2021 Aug 05
    View PubMed
  43. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Questions. Pediatr Nephrol. 2021 Dec; 36 (12):4083-4084 Epub 2021 Aug 05
    View PubMed
  44. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. Correction to: An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Answers. Pediatr Nephrol. 2021 Dec; 36 (12):4147
    View PubMed
  45. Dumancas CY, Chebib FT. Unilateral polycystic kidney disease. Kidney Int. 2021 Aug; 100 (2):483
    View PubMed
  46. Issa N, Chedid M, Irazabal MV, Dean PG, Chebib FT. Twenty-Year Survival of Kidney Transplant From a Deceased Donor With Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2021 Aug; 6 (8):2240-2242 Epub 2021 June 10
    View PubMed
  47. Suvakov S, Ghamrawi R, Cubro H, Tu H, White WM, Tobah YSB, Milic NM, Grande JP, Cunningham JM, Chebib FT, Prata LGPL, Zhu Y, Tchkonia T, Kirkland JL, Nath KA, Milosavljevic A, Garovic VD. Epigenetic and senescence markers indicate an accelerated ageing-like state in women with preeclamptic pregnancies. EBioMedicine. 2021 Aug; 70:103536 Epub 2021 Aug 11
    View PubMed
  48. Chebib FT, Torres VE. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy. Am J Kidney Dis. 2021 Aug; 78 (2):282-292 Epub 2021 Mar 08
    View PubMed
  49. Hanna C, Potretzke TA, Cogal AG, Mkhaimer YG, Tebben PJ, Torres VE, Lieske JC, Harris PC, Sas DJ, Milliner DS, Chebib FT. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency. Kidney Int Rep. 2021 Jul; 6 (7):1895-1903 Epub 2021 May 12
    View PubMed
  50. Shukoor SS, Vaughan LE, Edwards ME, Lavu S, Kline TL, Senum SR, Mkhaimer Y, Zaatari G, Irazabal MV, Neal R, Hogan MC, Zoghby ZM, Harris PC, Torres VE, Chebib FT. Characteristics of Patients with End-Stage Kidney Disease in ADPKD. Kidney Int Rep. 2021 Mar; 6 (3):755-767 Epub 2020 Dec 31
    View PubMed
  51. Suwabe T, Chamberlain AM, Killian JM, King BF, Gregory AV, Madsen CD, Wang X, Kline TL, Chebib FT, Hogan MC, Kamath PS, Harris PC, Torres VE. Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county. JHEP Rep. 2020 Dec; 2 (6):100166 Epub 2020 Aug 04
    View PubMed
  52. Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, Harris PC, HALT PKD and CRISP Study Investigators. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. JCI Insight. 2020 Aug 6; 5 (15) Epub 2020 Aug 06
    View PubMed
  53. Sussman CR, Wang X, Chebib FT, Torres VE. Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling. Cell Signal. 2020 Aug; 72:109649 Epub 2020 Apr 23
    View PubMed
  54. Huynh VT, Audrezet MP, Sayer JA, Ong AC, Lefevre S, Le Brun V, Despres A, Senum SR, Chebib FT, Barroso-Gil M, Patel C, Mallett AJ, Goel H, Mallawaarachchi AC, Van Eerde AM, Ponlot E, Kribs M, Le Meur Y, Harris PC, Cornec-Le Gall E, Genkyst Study Group, Genomics England Research Consortium. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. Kidney Int. 2020 Aug; 98 (2):476-487 Epub 2020 Mar 23
    View PubMed
  55. Singh P, Chebib FT, Cogal AG, Gavrilov DK, Harris PC, Lieske JC. Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation. Kidney Int Rep. 2020 Jun; 5 (6):955-958 Epub 2020 Apr 13
    View PubMed
  56. Skousen T, Safadi H, Young C, Karahanna E, Safadi S, Chebib F. Successful Moderation in Online Patient Communities: Inductive Case Study. J Med Internet Res. 2020 Mar 17; 22 (3):e15983
    View PubMed
  57. Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, Senum SR, Madsen CD, Chebib FT, Hogan MC, Cornec-Le Gall E, Harris PC, Torres VE. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County. Clin J Am Soc Nephrol. 2020 Jan 7; 15 (1):69-79 Epub 2019 Dec 02
    View PubMed
  58. Suvakov S, Cubro H, White WM, Butler Tobah YS, Weissgerber TL, Jordan KL, Zhu XY, Woollard JR, Chebib FT, Milic NM, Grande JP, Xu M, Tchkonia T, Kirkland JL, Lerman LO, Garovic VD. Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia. Biol Sex Differ. 2019 Sep 14; 10 (1):49 Epub 2019 Sept 14
    View PubMed
  59. Sanchis IM, Shukoor S, Irazabal MV, Madsen CD, Chebib FT, Hogan MC, El-Zoghby Z, Harris PC, Huston J, Brown RD, Torres VE. Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019 Aug 7; 14 (8):1151-1160 Epub 2019 July 30
    View PubMed
  60. Boonpheng B, Thongprayoon C, Wijarnpreecha K, Medaura J, Chebib FT, Cheungpasitporn W. Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis. Nephrology (Carlton). 2019 Jun; 24 (6):638-646 Epub 2019 Apr 23
    View PubMed
  61. Cheungpasitporn W, Thongprayoon C, Ungprasert P, Wijarnpreecha K, Kaewput W, Leeaphorn N, Bathini T, Chebib FT, Kröner PT. Subarachnoid Hemorrhage in Hospitalized Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis. J Clin Med. 2019 Apr 17; 8(4).
    View PubMed
  62. Wang X, Constans MM, Chebib FT, Torres VE, Pellegrini L. Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model. Am J Nephrol. 2019; 49 (6):487-493 Epub 2019 May 22
    View PubMed
  63. Chebib FT, Torres VE. Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2018 Nov 7; 13 (11):1765-1776 Epub 2018 July 26
    View PubMed
  64. Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. J Am Soc Nephrol. 2018 Oct; 29 (10):2458-2470 Epub 2018 Sept 18
    View PubMed
  65. Edwards ME, Chebib FT, Irazabal MV, Ofstie TG, Bungum LA, Metzger AJ, Senum SR, Hogan MC, El-Zoghby ZM, Kline TL, Harris PC, Czerwiec FS, Torres VE. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2018 Aug 7; 13 (8):1153-1161 Epub 2018 July 19
    View PubMed
  66. Cornec-Le Gall E, Chebib FT, Madsen CD, Senum SR, Heyer CM, Lanpher BC, Patterson MC, Albright RC, Yu AS, Torres VE, Harris PC, HALT Progression of Polycystic Kidney Disease Group Investigators. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations. Am J Kidney Dis. 2018 Aug; 72 (2):302-308 Epub 2018 Feb 01
    View PubMed
  67. Ye H, Wang X, Constans MM, Sussman CR, Chebib FT, Irazabal MV, Young WF Jr, Harris PC, Kirschner LS, Torres VE. The regulatory 1alpha subunit of protein kinase A modulates renal cystogenesis. Am J Physiol Renal Physiol. 2017 Sep 1; 313 (3):F677-F686 Epub 2017 June 14
    View PubMed
  68. Chebib FT, Hogan MC, El-Zoghby ZM, Irazabal MV, Senum SR, Heyer CM, Madsen CD, Cornec-Le Gall E, Behfar A, Harris PC, Torres VE. Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies. Kidney Int Rep. 2017 Sep; 2 (5):913-923 Epub 2017 June 06
    View PubMed
  69. Wang X, Yamada S, LaRiviere WB, Ye H, Bakeberg JL, Irazabal MV, Chebib FT, van Deursen J, Harris PC, Sussman CR, Behfar A, Ward CJ, Torres VE. Generation and phenotypic characterization of Pde1a mutant mice. PLoS One. 2017; 12 (7):e0181087 Epub 2017 July 27
    View PubMed
  70. Chebib FT, Harmon A, Irazabal Mira MV, Jung YS, Edwards ME, Hogan MC, Kamath PS, Torres VE, Nagorney DM. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease. J Am Coll Surg. 2016 Jul; 223 (1):118-126.e1 Epub 2016 Jan 14
    View PubMed
  71. Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2016 Jun; 31 (6):952-60 Epub 2016 Feb 29
    View PubMed
  72. Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. Am J Kidney Dis. 2016 May; 67 (5):792-810 Epub 2015 Oct 31
    View PubMed
  73. Jung Y, Irazabal MV, Chebib FT, Harris PC, Dean PG, Prieto M, Cosio FG, El-Zoghby ZM, Torres VE. Volume regression of native polycystic kidneys after renal transplantation. Nephrol Dial Transplant. 2016 Jan; 31 (1):73-9 Epub 2015 June 04
    View PubMed
  74. Chebib FT, Prieto M, Jung Y, Irazabal MV, Kremers WK, Dean PG, Rea DJ, Cosio FG, Torres VE, El-Zoghby ZM. Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease. Transplant Direct. 2015 Nov 1; 1 (10):e43 Epub 2015 Nov 18
    View PubMed
  75. Cheungpasitporn W, Chebib FT, Cornell LD, Brodin ML, Nasr SH, Schinstock CA, Stegall MD, Amer H. Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts. Transplantation. 2015 Nov; 99 (11):2382-6
    View PubMed
  76. Chebib FT, Sussman CR, Wang X, Harris PC, Torres VE. Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat Rev Nephrol. 2015 Aug; 11 (8):451-64 Epub 2015 Apr 14
    View PubMed
  77. Stewart AK, Chebib FT, Akbar SW, Salas MJ, Sonik RA, Shmukler BE, Alper SL. Interactions of mouse glycophorin A with the dRTA-related mutant G719D of the mouse Cl-HCO3- exchanger Ae1. Biochem Cell Biol. 2011 Apr; 89: (2)224-35.
    View PubMed
  78. Stewart AK, Vandorpe DH, Heneghan JF, Chebib F, Stolpe K, Akhavein A, Edelman EJ, Maksimova Y, Gallagher PG, Alper SL. The GPA-dependent, spherostomatocytosis mutant AE1 E758K induces GPA-independent, endogenous cation transport in amphibian oocytes. Am J Physiol Cell Physiol. 2010 Feb; 298: (2)C283-97.
    View PubMed
  79. Dai P, Stewart AK, Chebib F, Hsu A, Rozenfeld J, Huang D, Kang D, Lip V, Fang H, Shao H, Liu X, Yu F, Yuan H, Kenna M, Miller DT, Shen Y, Yang W, Zelikovic I, Platt OS, Han D, Alper SL, Wu BL. Distinct and novel SLC26A4Pendrin mutations in Chinese and U.S. patients with nonsyndromic hearing loss. Physiol Genomics. 2009 Aug 07; 38: (3)281-90.
    View PubMed